Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DA8MK6
|
|||
| Drug Name |
M6223
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C00-D48; ICD-9: 140-199] | Phase 1 | [1] | |
| Company |
EMD Serono
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | V-set and immunoglobulin domain-containing protein 9 (TIGIT) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Cell adhesion molecules (CAMs) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04457778) First in Human Study of M6223. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.